Clinical Trials Browser

Phase EARLY_PHASE1 × Gefitinib × 90 days × Clear all

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

Phase EARLY_PHASE1 Not yet recruiting

Lung Neoplasms